Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07064200 · ClinicalTrials.gov registry record · NA

TAP Block Timing Study

A NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT07064200: Recruiting NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries, sponsored by Weill Medical College of Cornell University.

NCT07064200 is a NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 150 participants, above the 93-participant average among 3 other Bariatric Surgery Patients trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07064200, a NA study of Bariatric Surgery Patients and Bariatric or General Abdominal Surgeries, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.

Primary Outcome

Opioid dosage quantities will be measured in morphine milligram equivalents (MME)

Interventions

  • OTHER TAP Block

Study Locations (1)

New York

  • Weill Cornell Medical College - NewYork-Presbyterian Hospital - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-07-14
Est. Completion 2027-07
Phase NA

What NCT07064200 shows while recruiting

NCT07064200 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 93-participant average among 3 other Bariatric Surgery Patients trials with a reported enrollment target (61% higher).

The record links to 2 conditions, with Bariatric Surgery Patients appearing as the primary indexed condition, and to 1 intervention - of which TAP Block is the first listed.

NCT07064200 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07064200 about?

NCT07064200 is a clinical study titled "TAP Block Timing Study". This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.

What is the current status of trial NCT07064200?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-07-14. Estimated completion is 2027-07.

What conditions does trial NCT07064200 study?

This clinical trial studies the following conditions: Bariatric Surgery Patients, Bariatric or General Abdominal Surgeries.

What interventions are being tested in trial NCT07064200?

The interventions under investigation include: TAP Block (OTHER).

Who is sponsoring clinical trial NCT07064200?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07064200 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bariatric Surgery Patients

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07064200, the US trial registry maintained by the National Library of Medicine. NCT07064200 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.